Satış Değişiklik Tarih
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
ALKERMES USD 480.13M 15.88M 2026-09
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 10.4B 300M 2026-09
Baxter International USD 2.98B 20M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.8B 60M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 74.04B 2.85B 2026-09
Dr.Reddys Laboratories INR 86.98B 6.27B 2026-09
Eisai JPY 235.63B 1.3B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Exelixis USD 658.69M 30M 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 32.83M 12.03M 2026-06
Merck USD 18.1B 1.5B 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Takeda JPY 1.19T 32.9B 2026-09
Teva Pharmaceutical Industries USD 4.37B 8.3B 2026-09
Xencor USD 116.52M 65.3M 2026-09